Roadmap Meeting on Precision Psychiatry

Validating biomarkers for precision psychiatry

Turning scientific promise into clinical progress

A pivotal 1.5-day meeting hosted by ECNP, dedicated to advancing the clinical application of precision psychiatry.

As part of ECNP’s Roadmap initiative to redefine the diagnostic framework for mental disorders, this high-impact event will spotlight the urgent need to move from conceptual frameworks to real-world implementation. Building on previous meetings that explored scientific foundations and methodological approaches, this meeting shifts the focus to biomarker-driven strategies aimed at revolutionising psychiatric drug development and patient care.

Why attend?

Precision psychiatry offers a transformative approach to understanding and treating mental illness—rooted in objective, biologically informed markers rather than symptom-based categories. This meeting will bring together all key stakeholders:

Regulatory authorities
Clinicians and researchers
Industry leaders
Health technology assessors
Payers and policymakers
Patient advocacy groups

Together, we will explore how biomarkers can:

Enable better patient stratification and dose selection
Improve clinical trial design and outcomes
Streamline regulatory and reimbursement pathways
Inform personalised treatment strategies in real-world settings

Key themes include:

Identifying the most urgent biomarker needs
Validating tools for clinical use
Replacing traditional diagnostic models with transdiagnostic, brain-based frameworks